51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04380831 (ClinicalTrials.gov)	February 24, 2022	30/4/2020	TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe System ...	Pilot Study of Total Body Irradiation Using Intensity Modulated Radiation Therapy (IMRT) and Cycloph ...	Systemic Scleroderma	Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;Drug: Cyclophosphamide;Radiation: Inte ...	City of Hope Medical Center	National Cancer Institute (NCI)	Recruiting	18 Years	65 Years	All	15	Early Phase 1	United States
2	NCT01047072 (ClinicalTrials.gov)	January 2010	11/1/2010	Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe System ...	Phase II Clinical Trial of Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Cond ...	Systemic Scleroderma	Drug: fludarabine phosphate;Radiation: total-body irradiation;Drug: tacrolimus;Drug: mycophenolate mof ...	Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	National Cancer Institute (NCI)	Withdrawn	18 Years	65 Years	Both	0	Phase 2	United States
3	NCT00622895 (ClinicalTrials.gov)	September 1, 2006	22/2/2008	Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis	Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With ...	Systemic Scleroderma;Severe Systemic Sclerosis	Drug: fludarabine phosphate;Drug: Mycophenolic Acid;Drug: tacrolimus;Radiation: total-body irradiatio ...	Fred Hutchinson Cancer Research Center	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	N/A	70 Years	All	3	Phase 1/Phase 2	United States
4	NCT00282425 (ClinicalTrials.gov)	May 2005	24/1/2006	Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis	Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation(NST) for Patients With Systemic ...	Scleroderma	Biological: Hematopoietic stem cell transplantation	Richard Burt, MD	NULL	Terminated	18 Years	55 Years	Both	8	Phase 1	United States

First Previous1Next Last